iRadimed Corporation
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
About
CEO
Mr. Roger E. Susi
Employees
148
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Devices
MIC code
XNMS
Address
1025 Willa Springs Drive, Winter Springs, FL 32708, United States
×
![Enlarged Chart]()
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Oct 29, 2025 | — | — | — | — |
| Jul 30, 2025 | — | — | — | — |
| Apr 30, 2025 | — | — | — | — |
| Feb 6, 2025 | 0.43 | — | — | — |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 2 | — | 2 |
| Average estimate | — | 0.41 | — | 1.75 |
| Low estimate | — | 0.40 | — | 1.72 |
| High estimate | — | 0.42 | — | 1.78 |
| Last year EPS | — | 0.36 | — | 1.66 |
[stock_revenue_estimate]
Growth estimates
Current qtr
12.820%
Next qtr. (Mar 2025)
13.890%
Current year
12.160%
Next year (Dec 2025)
5.420%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 65.56M | 53.30M | 41.81M | 31.72M | 38.52M |
| Cost of revenue | 15.40M | 12.02M | 9.76M | 8.14M | 8.82M |
| Gross profit | 50.16M | 41.28M | 32.05M | 23.57M | 29.70M |
| Operating expense | |||||
| Research & development | 2.86M | 2.28M | 1.91M | 1.90M | 1.43M |
| Selling general and admin | 27.26M | 23.38M | 20.33M | 22.43M | 19.62M |
| Other operating expenses | — | — | — | — | — |
| Operating income | 20.04M | 15.63M | 9.82M | -756,091 | 8.65M |
| Non operating interest income | |||||
| Income | 1.86M | 581,852 | 34,806 | 132,185 | 388,801 |
| Expense | — | — | — | — | — |
| Other income expense | -161,315 | -28,748 | -16,201 | 7,028 | 7,111 |
| Pretax income | 21.74M | 16.18M | 9.84M | -616,878 | 9.04M |
| Tax provision | 4.55M | 3.35M | 510,816 | -1.99M | -587,642 |
| Net income | 17.19M | 12.83M | 9.33M | 1.37M | 9.63M |
| Basic EPS | 1.36 | 1.02 | 0.76 | 0.11 | 0.85 |
| Diluted EPS | 1.35 | 1.02 | 0.74 | 0.11 | 0.78 |
| Basic average shares | 12.60M | 12.56M | 12.35M | 12.12M | 11.28M |
| Diluted average shares | 12.60M | 12.56M | 12.35M | 12.12M | 11.28M |
| EBITDA | 20.96M | 16.33M | 11.24M | 575,705 | 9.88M |
| Net income from continuing op. | 17.19M | 12.83M | 9.33M | 1.37M | 9.63M |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 92.16M | 85.51M | 82.88M | 71.07M | 66.73M |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 49.76M | 57.96M | 62.00M | 50.07M | 43.48M |
| Other short term investments | — | — | 501,855 | 1.91M | 2.77M |
| Accounts receivable | 12.22M | 13.27M | 5.14M | 4.57M | 7.29M |
| Other receivables | — | — | — | — | — |
| Inventory | 12.82M | 5.37M | 4.30M | 3.93M | 3.64M |
| Prepaid assets | — | 254,093 | 3.31M | 2.48M | 1.37M |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 1.19M | 630,960 | 1.00M | 771,666 | 407,802 |
| Non current assets | |||||
| Properties | 2.04M | 2.21M | 2.48M | 2.72M | 2.96M |
| Land and improvements | 6.25M | — | — | — | — |
| Machinery furniture equipment | 5.58M | 4.91M | 4.16M | 3.76M | 3.52M |
| Construction in progress | 1.26M | 665,773 | 537,043 | 470,446 | 163,105 |
| Leases | 270,486 | 259,146 | 237,086 | 230,351 | 225,841 |
| Accumulated depreciation | -4.07M | -3.43M | -2.86M | -2.34M | -1.85M |
| Goodwill | 2.52M | 2.07M | 1.12M | 960,885 | 860,087 |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 2.52M | 2.07M | 1.12M | 960,885 | 860,087 |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 2.30M | 1.35M | 966,421 | 1.53M | 1.90M |
| Total liabilities | 20.74M | 11.84M | 10.71M | 9.68M | 11.20M |
| Current liabilities | |||||
| Accounts payable | 1.86M | 1.80M | 782,903 | 657,054 | 993,742 |
| Accrued expenses | 2.78M | 2.87M | 2.81M | 1.71M | 2.17M |
| Short term debt | 427,963 | 293,466 | 276,568 | 255,698 | 240,843 |
| Deferred revenue | 2.57M | 3.37M | 2.55M | 1.95M | 1.67M |
| Tax payable | 353,282 | 121,919 | 140,315 | 103,981 | 596,576 |
| Pensions | — | — | — | — | — |
| Other current liabilities | 250,000 | — | 146,435 | 146,435 | 108,421 |
| Non current liabilities | |||||
| Long term debt | 1.62M | 1.91M | 2.21M | 2.46M | 2.72M |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | — | — | — | — | — |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | — | — | — | — | — |
| Shareholders equity | |||||
| Common stock | 1,265 | 1,259 | 1,254 | 1,231 | 1,177 |
| Retained earnings | 43.26M | 47.26M | 46.99M | 37.67M | 36.30M |
| Other shareholders equity | — | — | 17,012 | 37,087 | 30,374 |
| Total shareholders equity | 71.42M | 73.67M | 72.17M | 61.38M | 55.52M |
| Additional paid in capital | 28.16M | 26.41M | 25.16M | 23.68M | 19.19M |
| Treasury stock | — | — | — | — | — |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | 17.19M | 12.83M | 9.33M | 1.37M | 9.63M | 6.30M | 499,764 | 7.21M | 7.53M | 2.05M | 1.94M | 966,085 |
| Depreciation | 765,180 | 670,673 | 1.41M | 1.34M | 1.24M | 1.11M | 1.31M | 955,809 | 807,262 | 149,056 | 139,040 | 106,281 |
| Deferred Taxes | -1.17M | 57,097 | 523,607 | 389,932 | -596,755 | -144,430 | -150,657 | -570,910 | -16,116 | — | — | — |
| Stock-Based Compensation | 2.19M | 1.39M | 1.46M | 3.96M | 1.85M | 1.76M | 2.45M | 1.84M | 1.22M | 724,063 | 271,919 | 173,240 |
| Other Non-Cash Items | — | — | — | — | — | — | — | — | — | — | — | — |
| Accounts Receivable | 841,911 | -8.24M | -575,543 | 2.69M | -3.11M | -446,896 | -201,591 | 75,297 | -1.91M | 130,721 | -396,589 | -1.15M |
| Accounts Payable | -216,436 | 1.12M | 30,414 | -403,567 | 149,319 | 34,161 | -523,449 | 1,113 | 376,293 | 201,693 | 19,050 | 337,317 |
| Other Assets & Liabilities | -6.11M | -1.34M | -299,871 | -309,938 | 661,122 | -48,505 | 604,229 | 250,780 | 85,251 | -822,291 | -134,855 | 343,255 |
| Operating Cash Flow | 13.49M | 6.50M | 11.87M | 9.04M | 9.83M | 8.57M | 3.99M | 9.77M | 8.10M | 2.43M | 1.84M | 772,002 |
| Investing Activities | ||||||||||||
| Capital Expenditures | -7.44M | -823,019 | -482,325 | -443,003 | -368,281 | -228,315 | -775,574 | -780,809 | -298,723 | -583,977 | -163,175 | -112,940 |
| Net Intangibles | — | — | — | — | -117,531 | -36,350 | -49,189 | -743,486 | -16,116 | -22,311 | -28,586 | -48,621 |
| Net Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — |
| Purchase of Investments | — | — | — | — | — | -1.12M | -2.69M | -4.99M | — | -7.95M | -4,986 | -4,707 |
| Sale of Investments | — | 500,000 | 1.39M | 883,715 | 3.69M | 2.91M | 2.50M | 4.58M | 253,370 | 255,109 | — | — |
| Investing Cash Flow | -7.44M | -323,019 | 907,675 | 440,712 | 3.32M | 1.55M | -974,309 | -1.20M | -45,353 | -8.28M | -168,161 | -117,647 |
| Financing Activities | ||||||||||||
| Long-Term Debt Issuance | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | — | — | — | — | — | — | — | — | — | -6,333 | -513,397 | -238,532 |
| Other Financing Charges | -610,348 | -293,981 | -598,817 | -1.21M | -473,143 | -309,561 | -158,140 | 603,553 | 1.73M | -1.88M | — | — |
| Financing Cash Flow | -13.83M | -12.85M | -598,817 | -1.21M | -473,143 | -309,561 | -1.98M | -9.37M | 1.73M | 12.60M | -513,397 | -238,532 |
| Other Cash Details | ||||||||||||
| End Cash Position | 49.76M | 57.96M | 62.00M | 50.07M | 43.48M | 28.03M | 18.21M | 17.71M | 19.37M | 9.45M | 2.46M | 1.70M |
| Income Tax Paid | 5.35M | 1.71M | 970,000 | — | 12,000 | 1.38M | 1.21M | 3.39M | 2.70M | 1.18M | 1.39M | — |
| Interest Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 5.46M | 8.17M | 10.52M | 5.18M | 9.75M | 7.11M | 2.59M | 7.88M | 7.33M | 1.98M | 1.28M | 1.35M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 260,303 | 16.31M | 2.05% |
| iShares Russell 2000 ETF | Nov 30, 2024 | 186,990 | 11.72M | 1.48% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 127,496 | 7.99M | 1.01% |
| Fidelity Small Cap Index Fund | Oct 31, 2024 | 83,329 | 5.22M | 0.66% |
| Russell Inv Co-U.S. Small Cap Equity Fund | Oct 31, 2024 | 72,985 | 4.57M | 0.58% |
| iShares Russell 2000 Growth ETF | Nov 30, 2024 | 72,730 | 4.56M | 0.57% |
| BlackRock Advantage Small Cap Core Fund | Nov 30, 2024 | 60,544 | 3.79M | 0.48% |
| BlackRock Advantage Small Cap Growth Fund | Sep 30, 2024 | 59,851 | 3.75M | 0.47% |
| DFA U.S. Small Cap Series | Oct 31, 2024 | 57,164 | 3.58M | 0.45% |
| DFA U.S. Micro Cap Series | Oct 31, 2024 | 56,210 | 3.52M | 0.44% |
Article
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, February 13, 2025. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
Jan 30, 2025
Article
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
WINTER SPRINGS, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging compatible medical devices, today reported preliminary unaudited revenue for the fourth quarter and fiscal year ended December 31, 2024.
Jan 10, 2025
Article
iRadimed (IRMD) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, iRadimed (IRMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Dec 30, 2024
